GSS and cancer: TalaA suppresses the growth of CRC cells through two pathways: (1) by elevation of cancer cell ROS level to initiate ferroptosis; (2) by alteration of the expression of ferroptosis-related molecules (e.g., SLC7A11, ALOXE3, GSS, and HMOX1), which accelerates ferroptosis.